Effect of clofibrate administration on the urinary vanilmandelic acid method of Pisano et al.
D000924:Anticholesteremic Agents / Q000494:pharmacology; D002395:Catecholamines / Q000652:urine; D002994:Clofibrate / Q000494:pharmacology; D005965:Glucuronates / Q000494:pharmacology; D005966:Glucuronidase / Q000652:urine; D006801:Humans; D008333:Mandelic Acids / Q000037:antagonists & inhibitors / Q000652:urine*; D008722:Methods; D010627:Phenethylamines / Q000652:urine; D011422:Propionates / Q000494:pharmacology*; D014642:Vanilmandelic Acid / Q000032:analysis / Q000652:urine
D000924:Anticholesteremic Agents; D002395:Catecholamines; D005965:Glucuronates; D008333:Mandelic Acids; D010627:Phenethylamines; D011422:Propionates; D014642:Vanilmandelic Acid; D005966:Glucuronidase; D002994:Clofibrate